These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The effect of diet on the ophthalmological, clinical and biochemical aspects of Richner-Hanhart syndrome: a morphological ultrastructural study of the cornea and the conjunctiva. Sammartino A; Cerbella R; Cecio A; De Crecchio G; Federico A; Fronterre A Int Ophthalmol; 1987 Aug; 10(4):203-12. PubMed ID: 3654059 [TBL] [Abstract][Full Text] [Related]
44. Bilateral keratopathy and tyrosinosis. Sandberg HO Acta Ophthalmol (Copenh); 1975 Nov; 53(5):760-4. PubMed ID: 242185 [TBL] [Abstract][Full Text] [Related]
45. Richner-Hanhart syndrome (tyrosinaemia-II) (report of four cases without ocular involvement). Rehák A; Selim MM; Yadav G Br J Dermatol; 1981 Apr; 104(4):469-75. PubMed ID: 6453606 [TBL] [Abstract][Full Text] [Related]
46. [The metabolic basis of the hyperphenylalaninemias and tyrosinemia]. Shintaku H Nihon Rinsho; 1992 Jul; 50(7):1542-7. PubMed ID: 1357201 [TBL] [Abstract][Full Text] [Related]
47. [Diagnosis and therapy of 6 inherited, metabolic diseases, leading to mental deficiency. 1]. Menne F; Enzenauer J; Matz D Med Klin; 1976 Apr; 71(17):724-8. PubMed ID: 775276 [No Abstract] [Full Text] [Related]
50. Tyrosinemia type II with incomplete Richner-Hanhart's syndrome. Lestringant GG Int J Dermatol; 1988; 27(1):43-4. PubMed ID: 2964425 [No Abstract] [Full Text] [Related]
51. [Hyperphenylalaninemia and other hyperaminoacidurias with mental retardation, detected by multiple screening]. Hyánek J Cas Lek Cesk; 1972; 111(8):176-8. PubMed ID: 5010326 [No Abstract] [Full Text] [Related]
52. [Hereditary tyrosinemia in an acute form: a case report (author's transl)]. Di Battista C; Rossi L; Marcelli P; Di Saverio P; Laudizi Z; Moretti P Pediatr Med Chir; 1981; 3(1):101-4. PubMed ID: 6975468 [No Abstract] [Full Text] [Related]
53. Herpetiform keratitis and palmoplantar hyperkeratosis: warning signs for Richner-Hanhart syndrome. Soares DC; Stroparo MN; Lian YC; Takakura CY; Wolf S; Betz R; Kim CA J Inherit Metab Dis; 2017 May; 40(3):461-462. PubMed ID: 27832414 [TBL] [Abstract][Full Text] [Related]
54. Tyrosinaemia II. Colditz PB; Yu JS; Billson FA; Rogers M; Molloy HF; O'Halloran M; Wilcken B Med J Aust; 1984 Aug; 141(4):244-5. PubMed ID: 6482766 [TBL] [Abstract][Full Text] [Related]
55. Persistent tyrosinemia associated with low activity of tyrosine aminotransferase. Andersson S; Nemeth A; Ohisalo J; Strandvik B Pediatr Res; 1984 Jul; 18(7):675-8. PubMed ID: 6147810 [TBL] [Abstract][Full Text] [Related]
56. [Tyrosinemia type II. Case report]. Benatiya AI; Bouayed MA; Touiza E; Daoudi K; Bhalil S; Elmesbahi I; Tahri H Bull Soc Belge Ophtalmol; 2005; (296):57-61. PubMed ID: 16050420 [TBL] [Abstract][Full Text] [Related]
57. [Sepsis, as the presenting form of hereditary tyrosinemia type I]. Iglesias Niubo J; Riudor Taravilla E; Goma Brufau AR; Civit Colas MA; Suñé Gracia JM; Bertrán Sanges JM; Gallart Catalá A An Esp Pediatr; 1988 Sep; 29(3):235-8. PubMed ID: 3057981 [TBL] [Abstract][Full Text] [Related]
58. [Disorders in the tyrosine metabolism. II. Tyrosinemia - a congenital metabolic disorder]. Vulović D; Hajduković R; Sindjić M; FilipovićD ; Dozić S Srp Arh Celok Lek; 1974 Jan; 102(1):9-20. PubMed ID: 4368107 [No Abstract] [Full Text] [Related]